Zevra Therapeutics, Inc. (ZVRA)

CIK 1434647 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Zevra Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Nov 5, 2026SCHEDULE 13G/A0000315066-26-002891
Nov 3, 20268-K0001434647-26-000085
Nov 3, 202610-Q0001434647-26-000087
Oct 13, 20261440001950047-26-010170
Oct 13, 202640001434647-26-000075
Aug 17, 202640001434647-26-000073
Aug 14, 2026SCHEDULE 13G/A0000919574-26-005266
Aug 14, 20261440001950047-26-008134
Aug 12, 202640001434647-26-000070
Aug 6, 2026SCHEDULE 13G/A0000315066-26-002197
Aug 5, 202610-Q0001434647-26-000068
Aug 5, 20268-K0001434647-26-000067
Jul 31, 2026SCHEDULE 13G0002100119-26-001518
Jul 8, 20261440001950047-26-006950
Jun 23, 202640001434647-26-000057
Jun 18, 202640001434647-26-000054
Jun 18, 202640001434647-26-000050
Jun 18, 202640001434647-26-000055
Jun 18, 202640001434647-26-000052
Jun 18, 202640001434647-26-000053
Jun 18, 202640001434647-26-000051
Jun 5, 20268-K0001434647-26-000041
May 29, 202640001434647-26-000037
May 13, 202640001434647-26-000034
May 11, 20261440001950047-26-004326